CompletedPhase 2NCT02468648
Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816
Studying Idiopathic subglottic stenosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Principal Investigator
- Marc G Ghany, M.D.National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Intervention
- Sofosbuvir(drug)
- Enrollment
- 72 target
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2015 – 2018
Study locations (1)
- National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02468648 on ClinicalTrials.govOther trials for Idiopathic subglottic stenosis
Additional recruiting or active studies for the same condition.